ddrg/super_eurlex huggingface dataset:
Prior notification of a concentration

(Case M.9619 – CDC/EDF/ENGIE/La Poste)

(Text with EEA relevance)

(2020/C 180/10)

1. On 19 May 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — the Caisse des Dépôts et Consignations (‘CDC’, France), — EDF Pulse Croissance Holding (France), belonging to the Électricité de France group (‘EDF’), — ENGIE (France), — La Poste SA (France) belonging to the La Poste group, controlled by CDC. CDC (comprising La Poste), EDF and Engie acquire within the meaning of Article 3(1)(b) and Article 3(4) of the Merger Regulation joint control of Archipels, a newly created company. The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are: — CDC is a public group which carries out tasks of general interest in support of public policies conducted by the State and local authorities. — EDF is mainly active in France and abroad in the electricity markets. In the digital trust sector, EDF’s sole activity consists in providing, free of charge, an EDF tool operating a blockchain which makes it possible to verify that a press release issued by EDF is authentic. — ENGIE is an international industrial and services group active in gas and electricity business and energy services. This group is not active in the digital trust sector, — La Poste is the historic operator of the postal service in France, organised into five main branches of activity, including the La Banque Postale branch, which carries out banking and insurance activities, and the Digital branch, which develops digital solutions and services, in particular through Docaposte, which offers customer identification, electronic signature and certification.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission no later than 10 days following the date on which this notification is published. The following reference should always be specified: M.9619 – CDC/EDF/ENGIE/La Poste Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Prior notification of a concentration

(Case M.9564 – LSEG/Refinitiv Business)

(Text with EEA relevance)

(2020/C 174/04)

1. On 13 May 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — London Stock Exchange Group plc (‘LSEG’, United Kingdom), — Refinitiv Business (the ‘Target’, United States). LSEG acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the Target. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for LSEG: an international financial markets infrastructure business. LSEG’s main activities are in (i) capital markets through international equity, exchange-traded funds, fixed income and derivatives venues (LSE, Borsa Italiana, MTS, Turquoise, and CurveGlobal Limited); (ii) post-trade and risk management through clearing houses (LCH and CC&G) and a custody and settlement business (Monte Titoli); (iii) information services through data products providers (e.g. index provider FTSE Russell); and (iv) technology services through trading, market surveillance and post-trade systems for organisations and exchanges, — for the Target: a financial markets data and infrastructure business. The Target is active in (i) data and analytics (e.g. through its desktop solution Eikon; its consolidated-real-time-data feed Elektron; its market data platform Thomson Reuters Enterprise Platform; and its index business); (ii) capital markets and workflow solutions (through Tradeweb, FXall, and Matching); and (iii) risk management services.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9564 – LSEG/Refinitiv Business Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Prior notification of a concentration

(Case M.9806 – Hyundai Capital Bank Europe/Sixt Leasing)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 196/07)

1. On 4 June 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Hyundai Capital Bank Europe GmbH (‘HCBE’, Germany), jointly controlled by Santander Consumer Bank AG (‘SCB’, Germany) and Hyundai Capital Services, Inc. (‘HCS’, South Korea), — Sixt Leasing SE (‘Sixt Leasing’, Germany). HCBE acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of Sixt Leasing. The concentration is accomplished by way of public bid announced on 21 February 2020.

2. The business activities of the undertakings concerned are: — for HCBE: a bank that is active in automotive financing services, including financial leases, and the distribution of insurances, in Germany. HCBE is jointly controlled by SCB and HCS. SCB and the Spain-based Santander group to which SCB belongs offer leasing and other automotive financing services and also distribute insurances in Germany, France and Austria and several other EEA countries. HCS is the financial services arm of the South Korean car manufacturing Hyundai Motor Group, — for Sixt Leasing: is a Germany-based company that offers automotive leasing and related fleet management services in Germany, France and Austria. The company also distributes insurances.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9806 – Hyundai Capital Bank Europe/Sixt Leasing Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Non-opposition to a notified concentration

(Case M.9845 – Davidson Kempner Capital Management/GoldenTree Asset Management/Quorum Health Corporation)

(Text with EEA relevance)

(2020/C 185/01)

On 28 May 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9845. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Prior notification of a concentration

(Case M.9828 – Blackstone/NIBC Holding)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 208/03)

1. On 15 June 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — The Blackstone Group Inc. (‘Blackstone’, USA), — NIBC Holding N.V. (‘NIBC’, Netherlands). Blackstone acquires within the meaning of Article 3(1)(b) of the Merger Regulation sole control of the whole of NIBC. The concentration is accomplished by way of public bid and purchase of shares.

2. The business activities of the undertakings concerned are: — for Blackstone: a global alternative asset manager, — for NIBC: a mid-sized bank which offers selected corporate and retail banking products and services predominantly in north-west Europe (including Netherlands and Germany).

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9828 – Blackstone/NIBC Holding Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Prior notification of a concentration

(Case M.9862 – Fiege/Reiner Kurzhals/Cornelius Brosche/Remondis/WDL)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 203/05)

1. On 9 June 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Fiege Logistik Stiftung & Co. KG (‘Fiege’, Germany), part of the Fiege group (Germany), — Remondis Assets & Services GmbH & Co. KG (‘Remondis’, Germany), part of the Remondis group (Germany), ultimately controlled by Rethmann SE & Co. KG (‘Rethmann’, Germany), — Westphalia DataLab GmbH (‘WDL’, Germany). Fiege, Remondis and the other shareholders, Professor Reiner Kurzhals and Mr Cornelius Brosche, acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of WDL. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — Fiege: belongs to the Fiege group, which provides various logistics services (mainly) in Germany, its home market, but also abroad, — Remondis: Remondis is the central administrative unit of the Remondis group. The Remondis group’s main activities are waste disposal, water treatment and recycling. The Remondis group is a division of the Rethmann group. The Rethmann group is organised into three divisions: water management and the circular economy; logistics; and food and feed, — WDL: advises companies in the field of data analytics and develops and markets software solutions for companies, based on artificial intelligence and in particular on machine learning, for business data analysis and business development forecasting, as well as software solutions for medical research.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under Council Regulation (EC) No 139/2004 (2), it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9862 – Fiege/Reiner Kurzhals/Cornelius Brosche/Remondis/WDL Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9736 – Lone Star/BASF Construction Chemicals (EB) Business)

(Text with EEA relevance)

(2020/C 217/08)

1. On 22 June 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Lone Star Funds (‘Lone Star’, USA), — BASF’s construction chemicals business (‘BASF’s EB business’, Germany) Lone Star acquires within the meaning of Article 3(1)(b) of the Merger Regulation control of the whole of BASF’s EB business. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — Lone Star: Private equity firm that invests globally in real estate, equity, credit and other financial assets, — BASF’s EB business: BASF’s construction chemicals business, consisting in two strategic business units: (i) ‘admixture systems’, which provides solutions for customers in the concrete manufacturing, cement and underground construction industries; and (ii) ‘construction systems’, which offers solutions to protect and repair buildings and structures.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9736 – Lone Star/BASF Construction Chemicals (EB) Business Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: E-mail COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).
Non-opposition to a notified concentration

(Case M.9700 – Dnata/Alpha LSG)

(Text with EEA relevance)

(2020/C 214/01)

On 6 March 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9700. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Non-opposition to a notified concentration

(Case M.9806 – Hyundai Capital Bank Europe/Sixt Leasing)

(Text with EEA relevance)

(2020/C 226/01)

On 3 July 2020, the Commission decided not to oppose the above notified concentration and to declare it compatible with the internal market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004 (1). The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

— in the merger section of the Competition website of the Commission (http://ec.europa.eu/competition/mergers/cases/). This website provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

— in electronic form on the EUR-Lex website (http://eur-lex.europa.eu/homepage.html?locale=en) under document number 32020M9806. EUR-Lex is the online access to European law.

(1) OJ L 24, 29.1.2004, p. 1.
Official Journal of the European Union

Prior notification of a concentration

(Case M.9884 – Thoma Bravo/Madison Dearborn Partners/Axiom)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 219/10)

1. On 25 June 2020, the Commission received notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Thoma Bravo LLC (‘Thoma Bravo’, USA), — Madison Dearborn Partners (‘MDP’, USA), — Axiom Software Business of Kaufman, Hall & Associates (‘Axiom’, USA). Thoma Bravo and MDP acquire within the meaning of Article 3(1)(b) and Article 3(4) of the Merger Regulation joint control of the whole of Axiom. The concentration is accomplished by way of purchase of shares.

2. The business activities of the undertakings concerned are: — for Thoma Bravo: private equity investment firm providing equity and strategic support, — for MDP: private equity investment firm, with focus in basic industries; business & government software and services; financial and transaction services; health care; and telecom, media and technology services, — for Axiom: the provision of a cloud-based, comprehensive EPM solution that includes budgeting, forecasting, reporting, analytics, strategy management, consolidations, capital planning, profitability modelling and cost management.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9884 – Thoma Bravo/Madison Dearborn Partners/Axiom Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.
Prior notification of a concentration

(Case M.9812 – Verily Life Sciences/Santen Pharmaceutical/JV)

Candidate case for simplified procedure

(Text with EEA relevance)

(2020/C 235/04)

1. On 9 July 2020, the Commission received notification of a proposed concentration pursuant to Article 4 and following a referral pursuant to Article 4(5) of Council Regulation (EC) No 139/2004 ( 1 ) This notification concerns the following undertakings: — Verily Life Sciences LLC (USA) (‘Verily’), controlled by Alphabet Inc. (USA), — Santen Pharmaceutical Company, Ltd. (Japan) (‘Santen’). Verily and Santen acquire within the meaning of Article 3(1)(b) and 3(4) of the Merger Regulation joint control of a newly formed joint venture. The concentration is accomplished by way of purchase of shares in a newly created company constituting a joint venture.

2. The business activities of the undertakings concerned are: — Verily focuses on life sciences and healthcare. It creates innovative tools and technologies to prevent and manage disease, partnering with life sciences, medical device and government organisations, — Santen is a pharmaceutical company focused on ophthalmology. It carries out research and development, marketing and sales of pharmaceutical products, — The joint venture will research, develop and commercialise a portfolio of ophthalmology devices designed to treat or diagnose eye disorders or otherwise provide tools to assist patients, caregivers, or providers to manage overall eye health.

3. On preliminary examination, the Commission finds that the notified transaction could fall within the scope of the Merger Regulation. However, the final decision on this point is reserved. Pursuant to the Commission Notice on a simplified procedure for treatment of certain concentrations under the Council Regulation (EC) No 139/2004 (2) it should be noted that this case is a candidate for treatment under the procedure set out in the Notice.

4. The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission. Observations must reach the Commission not later than 10 days following the date of this publication. The following reference should always be specified: M.9812 – Verily Life Sciences/Santen Pharmaceutical/JV Observations can be sent to the Commission by email, by fax, or by post. Please use the contact details below: Email: COMP-MERGER-REGISTRY@ec.europa.eu Fax +32 22964301 Postal address: European Commission Directorate-General for Competition Merger Registry 1049 Bruxelles/Brussel BELGIQUE/BELGIË

(1) OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’).

(2) OJ C 366, 14.12.2013, p. 5.